vs

Side-by-side financial comparison of Industrial Logistics Properties Trust (ILPT) and MEDIFAST INC (MED). Click either name above to swap in a different company.

Industrial Logistics Properties Trust is the larger business by last-quarter revenue ($113.9M vs $75.1M, roughly 1.5× MEDIFAST INC). On growth, Industrial Logistics Properties Trust posted the faster year-over-year revenue change (3.1% vs -36.9%). Industrial Logistics Properties Trust produced more free cash flow last quarter ($42.0M vs $-6.6M). Over the past eight quarters, Industrial Logistics Properties Trust's revenue compounded faster (0.7% CAGR vs -34.4%).

Industrial Logistics Properties Trust is a real estate investment trust that owns and operates a portfolio of industrial and logistics real estate assets primarily across the United States. Its holdings include distribution centers, warehouses, and last-mile delivery properties, serving e-commerce, retail, manufacturing and supply chain operators to meet their storage and logistics operation needs.

Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.

ILPT vs MED — Head-to-Head

Bigger by revenue
ILPT
ILPT
1.5× larger
ILPT
$113.9M
$75.1M
MED
Growing faster (revenue YoY)
ILPT
ILPT
+40.0% gap
ILPT
3.1%
-36.9%
MED
More free cash flow
ILPT
ILPT
$48.7M more FCF
ILPT
$42.0M
$-6.6M
MED
Faster 2-yr revenue CAGR
ILPT
ILPT
Annualised
ILPT
0.7%
-34.4%
MED

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ILPT
ILPT
MED
MED
Revenue
$113.9M
$75.1M
Net Profit
$-1.8M
Gross Margin
69.4%
Operating Margin
-22.1%
-10.4%
Net Margin
-1.6%
Revenue YoY
3.1%
-36.9%
Net Profit YoY
92.6%
EPS (diluted)
$-0.02
$-1.64

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ILPT
ILPT
MED
MED
Q4 25
$113.9M
$75.1M
Q3 25
$110.9M
$89.4M
Q2 25
$112.1M
$105.6M
Q1 25
$111.9M
$115.7M
Q4 24
$110.5M
$119.0M
Q3 24
$108.9M
$140.2M
Q2 24
$110.6M
$168.6M
Q1 24
$112.2M
$174.7M
Net Profit
ILPT
ILPT
MED
MED
Q4 25
$-1.8M
Q3 25
$-21.6M
$-2.3M
Q2 25
$-21.3M
$2.5M
Q1 25
$-21.5M
$-772.0K
Q4 24
$-24.1M
Q3 24
$-25.0M
$1.1M
Q2 24
$-23.2M
$-8.2M
Q1 24
$-23.4M
$8.3M
Gross Margin
ILPT
ILPT
MED
MED
Q4 25
69.4%
Q3 25
69.5%
Q2 25
72.6%
Q1 25
72.8%
Q4 24
74.1%
Q3 24
75.4%
Q2 24
73.2%
Q1 24
72.8%
Operating Margin
ILPT
ILPT
MED
MED
Q4 25
-22.1%
-10.4%
Q3 25
-29.4%
-4.6%
Q2 25
-30.8%
-1.0%
Q1 25
-26.9%
-1.1%
Q4 24
-31.1%
0.6%
Q3 24
-33.5%
1.5%
Q2 24
-32.4%
-4.7%
Q1 24
-31.7%
4.5%
Net Margin
ILPT
ILPT
MED
MED
Q4 25
-1.6%
Q3 25
-19.4%
-2.5%
Q2 25
-19.0%
2.3%
Q1 25
-19.2%
-0.7%
Q4 24
-21.8%
Q3 24
-22.9%
0.8%
Q2 24
-20.9%
-4.8%
Q1 24
-20.9%
4.8%
EPS (diluted)
ILPT
ILPT
MED
MED
Q4 25
$-0.02
$-1.64
Q3 25
$-0.33
$-0.21
Q2 25
$-0.32
$0.22
Q1 25
$-0.33
$-0.07
Q4 24
$-0.37
$0.08
Q3 24
$-0.38
$0.10
Q2 24
$-0.35
$-0.75
Q1 24
$-0.36
$0.76

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ILPT
ILPT
MED
MED
Cash + ST InvestmentsLiquidity on hand
$94.8M
$167.3M
Total DebtLower is stronger
$4.2B
Stockholders' EquityBook value
$489.7M
$198.9M
Total Assets
$5.2B
$248.0M
Debt / EquityLower = less leverage
8.56×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ILPT
ILPT
MED
MED
Q4 25
$94.8M
$167.3M
Q3 25
$83.2M
$173.5M
Q2 25
$58.6M
$162.7M
Q1 25
$108.0M
$164.6M
Q4 24
$131.7M
$162.3M
Q3 24
$153.9M
$170.0M
Q2 24
$146.2M
$163.5M
Q1 24
$128.4M
$156.4M
Total Debt
ILPT
ILPT
MED
MED
Q4 25
$4.2B
Q3 25
$4.2B
Q2 25
$4.2B
Q1 25
$4.3B
Q4 24
$4.3B
Q3 24
$4.3B
Q2 24
$4.3B
Q1 24
$4.3B
Stockholders' Equity
ILPT
ILPT
MED
MED
Q4 25
$489.7M
$198.9M
Q3 25
$494.1M
$214.7M
Q2 25
$519.1M
$216.0M
Q1 25
$539.5M
$211.0M
Q4 24
$562.0M
$210.1M
Q3 24
$585.9M
$207.3M
Q2 24
$618.3M
$205.3M
Q1 24
$643.2M
$211.0M
Total Assets
ILPT
ILPT
MED
MED
Q4 25
$5.2B
$248.0M
Q3 25
$5.2B
$268.2M
Q2 25
$5.2B
$269.3M
Q1 25
$5.4B
$280.0M
Q4 24
$5.4B
$284.2M
Q3 24
$5.5B
$291.2M
Q2 24
$5.5B
$293.5M
Q1 24
$5.5B
$302.8M
Debt / Equity
ILPT
ILPT
MED
MED
Q4 25
8.56×
Q3 25
8.49×
Q2 25
8.09×
Q1 25
7.96×
Q4 24
7.65×
Q3 24
7.35×
Q2 24
6.96×
Q1 24
6.70×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ILPT
ILPT
MED
MED
Operating Cash FlowLast quarter
$60.7M
$-5.3M
Free Cash FlowOCF − Capex
$42.0M
$-6.6M
FCF MarginFCF / Revenue
36.9%
-8.8%
Capex IntensityCapex / Revenue
16.4%
1.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$79.8M
$1.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ILPT
ILPT
MED
MED
Q4 25
$60.7M
$-5.3M
Q3 25
$22.7M
$12.1M
Q2 25
$18.4M
$-3.4M
Q1 25
$11.4M
$3.4M
Q4 24
$2.0M
$-4.9M
Q3 24
$-3.4M
$9.1M
Q2 24
$10.8M
$13.1M
Q1 24
$8.0M
$7.3M
Free Cash Flow
ILPT
ILPT
MED
MED
Q4 25
$42.0M
$-6.6M
Q3 25
$17.6M
$10.8M
Q2 25
$15.2M
$-4.8M
Q1 25
$5.0M
$1.9M
Q4 24
$-3.7M
$-7.2M
Q3 24
$-5.9M
$7.7M
Q2 24
$9.4M
$11.1M
Q1 24
$5.9M
$5.4M
FCF Margin
ILPT
ILPT
MED
MED
Q4 25
36.9%
-8.8%
Q3 25
15.9%
12.0%
Q2 25
13.5%
-4.5%
Q1 25
4.5%
1.6%
Q4 24
-3.4%
-6.1%
Q3 24
-5.5%
5.5%
Q2 24
8.5%
6.6%
Q1 24
5.2%
3.1%
Capex Intensity
ILPT
ILPT
MED
MED
Q4 25
16.4%
1.8%
Q3 25
4.6%
1.5%
Q2 25
2.9%
1.3%
Q1 25
5.7%
1.3%
Q4 24
5.2%
1.9%
Q3 24
2.3%
1.0%
Q2 24
1.3%
1.1%
Q1 24
1.9%
1.1%
Cash Conversion
ILPT
ILPT
MED
MED
Q4 25
Q3 25
Q2 25
-1.36×
Q1 25
Q4 24
Q3 24
8.04×
Q2 24
Q1 24
0.88×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons